Is Moderna Stock Outperforming the Dow? [Yahoo! Finance]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: Yahoo! Finance
With a market cap of $19.7 billion, Moderna, Inc. (MRNA) is a biotechnology company specializing in messenger RNA (mRNA) medicines, with operations across the United States, Europe, and global markets. Its broad vaccine portfolio spans respiratory diseases (including COVID-19, RSV, influenza, and pandemic influenza), latent and enteric viruses, public health threats such as Zika and Mpox, and bacterial diseases like Lyme disease. Companies valued at $10 billion or more are generally considered "large-cap" stocks and Moderna fits this criterion perfectly. Moderna also develops oncology therapeutics ranging from cancer vaccines to T-cell engagers, as well as treatments for rare diseases, including cystic fibrosis and metabolic disorders. More News from Barchart Dear Costco Stock Fans, Mark Your Calendars for March 5 SanDisk Stock Forecast: Can the Rally Continue Into 2026? Dear Broadcom Stock Fans, Mark Your Calendars for March 4 Get exclusive insights with the FREE Barchar
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Is BioNTech SE (BNTX) A Good Stock To Buy Now? [Yahoo! Finance]Yahoo! Finance
- Moderna (MRNA) Climbs 16% as Arbutus-Genevant Legal Battle Clears [Yahoo! Finance]Yahoo! Finance
- The Sun Will Shine On Moderna Again - Initiating With A Buy [Seeking Alpha]Seeking Alpha
- Why Moderna's $950M Patent Bill Is A Small Price For Pipeline Freedom [Seeking Alpha]Seeking Alpha
- Moderna to pay up to $2.25B to settle COVID vaccine patent matter [Yahoo! Finance]Yahoo! Finance
MRNA
Earnings
- 2/13/26 - Beat
MRNA
Sec Filings
- 3/5/26 - Form 8-K
- 3/3/26 - Form 4
- 3/3/26 - Form 4
- MRNA's page on the SEC website